SymBio Pharmaceuticals
4582.TTSE GROWTHPharmaceutical
In English · 42
Fri, Sep 18 · JST1 filing
11:495% STAKESymBio Pharmaceuticals · Evo Fund + 1 joint holder · 57.40% → 56.25%−1.15ppWed, Sep 9 · JST1 filing
13:165% STAKESymBio Pharmaceuticals · Evo Fund + 1 joint holder · 6.44% → 57.40%+50.96ppMon, Sep 7 · JST1 filing
11:295% STAKESymBio Pharmaceuticals · Evo Fund + 1 joint holder · 26.61% → 6.44%−20.17ppTue, Aug 25 · JST1 filing
13:175% STAKESymBio Pharmaceuticals · Evo Fund + 1 joint holder · 23.82% → 26.61%+2.79ppWed, Aug 5 · JST2 filings
16:055% STAKESymBio Pharmaceuticals · YOSHIDA FUMINORI · 6.35%new 6.35%09:565% STAKESymBio Pharmaceuticals · Evo Fund + 1 joint holder · 27.55% → 23.82%−3.73ppWed, Jul 8 · JST1 filing
13:025% STAKESymBio Pharmaceuticals · Evo Fund + 1 joint holder · 25.91% → 27.55%+1.64ppMon, Jul 6 · JST1 filing
13:235% STAKESymBio Pharmaceuticals · Evo Fund + 1 joint holder · 28.30% → 25.91%−2.39ppWed, May 13 · JST1 filing
11:335% STAKESymBio Pharmaceuticals · Evo Fund + 1 joint holder · 22.44% → 28.30%+5.86ppFri, May 8 · JST1 filing
14:175% STAKESymBio Pharmaceuticals · Evo Fund + 1 joint holder · 22.90% → 22.44%−0.46ppWed, Apr 22 · JST1 filing
11:245% STAKESymBio Pharmaceuticals · Evo Fund + 1 joint holder · 23.69% → 22.90%−0.79ppThu, Apr 16 · JST1 filing
11:465% STAKESymBio Pharmaceuticals · Evo Fund + 1 joint holder · 24.36% → 23.69%−0.67ppWed, Apr 8 · JST1 filing
11:365% STAKESymBio Pharmaceuticals · Evo Fund + 1 joint holder · 25.23% → 24.36%−0.87ppWed, Mar 4 · JST1 filing
14:185% STAKESymBio Pharmaceuticals · Cantor Fitzgerald Europe · 9.26% → 7.35%−1.91ppMon, Mar 2 · JST1 filing
13:035% STAKESymBio Pharmaceuticals · Cantor Fitzgerald Europe · 13.68% → 9.26%−4.42ppThu, Feb 26 · JST1 filing
13:575% STAKESymBio Pharmaceuticals · Evo Fund + 1 joint holder · 25.91% → 25.23%−0.68ppWed, Feb 25 · JST1 filing
12:575% STAKESymBio Pharmaceuticals · Evo Fund + 1 joint holder · 26.54% → 25.91%−0.63ppWed, Feb 18 · JST1 filing
11:265% STAKESymBio Pharmaceuticals · Evo Fund + 1 joint holder · 27.40% → 26.54%−0.86ppTue, Feb 10 · JST1 filing
09:125% STAKESymBio Pharmaceuticals · Evo Fund + 1 joint holder · 28.03% → 27.40%−0.63ppMon, Jan 26 · JST1 filing
12:365% STAKESymBio Pharmaceuticals · Evo Fund + 1 joint holder · 28.52% → 28.03%−0.49ppThu, Jan 22 · JST1 filing
12:525% STAKESymBio Pharmaceuticals · Evo Fund + 1 joint holder · 29.13% → 28.52%−0.61ppFri, Jan 16 · JST1 filing
14:105% STAKESymBio Pharmaceuticals · Evo Fund + 1 joint holder · 29.85% → 29.13%−0.72ppTue, Jan 13 · JST1 filing
13:595% STAKESymBio Pharmaceuticals · Evo Fund + 1 joint holder · 28.85% → 29.85%+1.00ppFri, Jan 9 · JST1 filing
15:295% STAKESymBio Pharmaceuticals · Evo Fund + 1 joint holder · 30.17% → 28.85%−1.32ppThu, Jan 8 · JST1 filing
14:315% STAKESymBio Pharmaceuticals · Evo Fund + 1 joint holder · 31.14% → 30.17%−0.97ppThu, Dec 25 · JST1 filing
14:015% STAKESymBio Pharmaceuticals · Evo Fund + 1 joint holder · 31.67% → 31.14%−0.53ppFri, Dec 5 · JST1 filing
14:485% STAKESymBio Pharmaceuticals · Evo Fund + 1 joint holder · 32.27% → 31.67%−0.60ppMon, Nov 17 · JST1 filing
12:045% STAKESymBio Pharmaceuticals · Evo Fund + 1 joint holder · 32.80% → 32.27%−0.53ppWed, Oct 29 · JST1 filing
13:465% STAKESymBio Pharmaceuticals · Evo Fund + 1 joint holder · 33.20% → 32.80%−0.40ppFri, Oct 17 · JST1 filing
14:185% STAKESymBio Pharmaceuticals · Evo Fund + 1 joint holder · 33.74% → 33.20%−0.54ppThu, Sep 25 · JST1 filing
13:275% STAKESymBio Pharmaceuticals · Evo Fund + 1 joint holder · 34.44% → 33.74%−0.70ppWed, Sep 10 · JST1 filing
11:115% STAKESymBio Pharmaceuticals · Evo Fund + 1 joint holder · 34.55% → 34.44%−0.11ppFri, Aug 29 · JST1 filing
13:545% STAKESymBio Pharmaceuticals · Evo Fund + 1 joint holder · 35.16% → 34.55%−0.61ppTue, Aug 19 · JST1 filing
12:545% STAKESymBio Pharmaceuticals · Evo Fund + 1 joint holder · 35.16%new 35.16%Wed, Apr 16 · JST1 filing
16:095% STAKESymBio Pharmaceuticals · Cantor Fitzgerald Europe · 7.44% → 13.68%+6.24ppTue, Mar 25 · JST1 filing
10:055% STAKESymBio Pharmaceuticals · Cantor Fitzgerald Europe · 9.11% → 7.44%−1.67ppFri, Feb 28 · JST1 filing
13:575% STAKESymBio Pharmaceuticals · Cantor Fitzgerald Europe · 10.22% → 9.11%−1.11ppMon, Feb 17 · JST1 filing
12:315% STAKESymBio Pharmaceuticals · Cantor Fitzgerald Europe · 11.33% → 10.22%−1.11ppMon, Feb 10 · JST1 filing
12:515% STAKESymBio Pharmaceuticals · Cantor Fitzgerald Europe · 5.01% → 11.33%+6.32ppThu, Jan 23 · JST1 filing
10:265% STAKESymBio Pharmaceuticals · Cantor Fitzgerald Europe · 6.67% → 5.01%−1.66ppThu, Jan 16 · JST1 filing
14:445% STAKESymBio Pharmaceuticals · Cantor Fitzgerald Europe · 6.67%new 6.67%Thu, Jul 25 · JST1 filing
15:235% STAKESymBio Pharmaceuticals · Heights Capital Management, Inc. · 7.22% → 4.18%−3.04ppAll EDINET filings · 125
| Filed | Document | Source |
|---|---|---|
| 2026-10-02 | Large shareholding reportRelated to S100WK08 | S100Z5L6 |
| 2026-09-18 | Large shareholding reportRelated to S100WK08 | S100Z2RZ |
| 2026-09-09 | Large shareholding reportRelated to S100WK08 | S100Z0ZR |
| 2026-09-07 | Large shareholding reportRelated to S100WK08 | S100Z0OU |
| 2026-08-25 | Large shareholding reportRelated to S100YUCP | S100YY0M |
| 2026-08-25 | Amended large shareholding reportAmends S100YUCP | S100YY6Y |
| 2026-08-25 | Large shareholding reportRelated to S100WK08 | S100YYH2 |
| 2026-08-21 | Amended securities registrationRelated to S100YWCL | S100YXVZ |
| 2026-08-17 | Securities registration | S100YWCL |
| 2026-08-10 | CEO/CFO certification | S100YVT2 |
| 2026-08-10 | Half-year report | S100YVSZ |
| 2026-08-05 | Large shareholding report | S100YUCP |
| 2026-08-05 | Large shareholding reportRelated to S100WK08 | S100YTTB |
| 2026-07-08 | Large shareholding reportRelated to S100WK08 | S100YPA2 |
| 2026-07-06 | Large shareholding reportRelated to S100WK08 | S100YOV6 |
| 2026-05-13 | Large shareholding reportRelated to S100WK08 | S100Y2LW |
| 2026-05-08 | Large shareholding reportRelated to S100WK08 | S100Y25R |
| 2026-04-22 | Large shareholding reportRelated to S100WK08 | S100Y03B |
| 2026-04-17 | Amended material event reportAmends S100XSAL | S100XZH8 |
| 2026-04-16 | Large shareholding reportRelated to S100WK08 | S100XYQP |
| 2026-04-08 | Large shareholding reportRelated to S100WK08 | S100XXJC |
| 2026-03-25 | Material event report | S100XSAO |
| 2026-03-24 | Material event report | S100XSAL |
| 2026-03-24 | CEO/CFO certification | S100XNE6 |
| 2026-03-24 | Internal control report | S100XS9L |
| 2026-03-24 | Annual report | S100XNE5 |
| 2026-03-04 | Large shareholding report | S100XOSF |
| 2026-03-02 | Amended large shareholding reportAmends S100XO5M | S100XO6F |
| 2026-03-02 | Large shareholding report | S100XO5M |
| 2026-02-26 | Large shareholding reportRelated to S100WK08 | S100XN52 |
EDINET catalog 2017-01-01 → 2026-10-03; earlier dates still being collected. 22 financial reports not structured yet.
Not structured yet
| 2022-03-31 | quarterly | original indexed | S100O0HR |
| 2021-12-31 | annual | original indexed | S100NPZC |
| 2021-09-30 | quarterly | original indexed | S100MUIG |
| 2021-06-30 | quarterly | original indexed | S100M4A8 |
| 2021-03-31 | quarterly | original indexed | S100LCC8 |
| 2020-12-31 | annual | original indexed | S100L0KX |
| 2020-09-30 | quarterly | original indexed | S100K4I1 |
| 2020-06-30 | quarterly | original indexed | S100JES6 |
| 2020-03-31 | quarterly | original indexed | S100IKKQ |
| 2019-12-31 | annual | original indexed | S100IB4B |
| 2019-09-30 | quarterly | original indexed | S100HBOL |
| 2019-06-30 | quarterly | original indexed | S100GOF0 |
| 2019-03-31 | quarterly | original indexed | S100FSHV |
| 2018-12-31 | annual | original indexed | S100FI8O |
| 2018-09-30 | quarterly | original indexed | S100EIPC |
| 2018-06-30 | quarterly | original indexed | S100DTPD |
| 2018-03-31 | quarterly | original indexed | S100CXTU |
| 2017-12-31 | annual | original indexed | S100COXH |
| 2017-09-30 | quarterly | pending download | S100BRNW |
| 2017-06-30 | quarterly | pending download | S100B07B |
| 2017-03-31 | quarterly | pending download | S100A7KX |
| 2016-12-31 | annual | pending download | S100A097 |